Wistar-Kyoto rats (WKY) were intra-~te~ally infused with angiotensin II (AII) or phenyleph~ne for 10 min. Both vasoactive compounds produced an initial increase in co&ear blood flow (CoBF) as measured by laser Doppler flowmetry, followed by a slow steady return to baseline, despite sustained elevations in systemic blood pressure. These results suggest autoregulation of CoBF in the WKY rat. In a second experiment, AI1 was infused directly into the anterior inferior cerebellar artery (AICA) which feeds the co&ear artery. Significant reductions in CoBF were noted without changes in systemic blood pressure. Pretreatment with the specific angiotensin-receptor antagonist, sarthran (Sar', Thr*-AH), diminished subsequent AH-induced reductions in CoBF. These results indicate that AI1 binding to vascular receptors may induce v~~onst~ction in the supplying vessels of the cochlea, and thus, the interaction of blood-borne AI1 and vascular angiotensin receptors may participate in the autoregulation of CoBF.
Introduction
Previous research has demonstrated that cochlear blood flow (CoBF) can be driven by changes in systemic blood pressure (Goodwin et al., 1984; Miller et al., 1983 Miller et al., , 1984 Snow and Suga, 1972; Suga and Snow, 1969; Wright et al., 1985a) . For example, increases in CoBF occur with elevated blood pressure in response to epinephrine and ephedrine (Snow and Suga, 1972) , angiotensin II (Goodwin et al., 1984; Quirk et al., 1988; Snow and Suga, 1972) , nicotine (Dengerink et al., 1985; Laugel et al., 1988) , phenylep~ine (Laugel et al., 1988; Sillman et al., 1988) , and methoxamine (Miller et al., 1984) . There are also indications that CoBF may be subject to local autoregulation (Dengerink et al., 1985; Goodwin et al., 1984; Hultcr~tz et al., 1982; Miller and Dengerink, 1988; Miller et al., 1984; Quirk et al., 1988) .
Classically, autoregulation is defined as the ability of a tissue to maintain relatively constant flow despite variations in perfusion pressure (Bayliss, 1902) . Autoregulation of the cerebral vessels has been well documented in normotensive (Coyle and Heistad, 1986) and spontaneously hypertensive rats (Baumbach and Heistad, 1985; Harper and Bohlen, 1981; Sadoshima et al., 1985) , cats (Chang et al., 19851, newborn canines (Pasternak and Groothius, 1985) and baboons (Strandgaard et al., 1975) .
Since several authors have proposed that CoBF may be closely related to cerebral blood flow (Lawrence et al., 1977; Miller et al., 19831 , evidence of co&ear blood flow autoregulation should not be a surprising discovery. Indeed, autoregulation of CoBF has been demonstrated during large deviations in blood pressure (Flynn et al., 1988; LaRouere et al., 1988; Quirk et al., 1988) . In one case, positive end expiratory pressure (PEEP) induced large decreases in blood pressure in guinea pigs that resulted in initial decreases in CoBF, followed by a slow, steady increase in CoBF toward baseline measures (LaRouere et al., 1988) . In another example, intra cerebroventricular infu-sions of angiotensin II (AH) in guinea pigs induced sustained elevations in blood pressure and transient increases of CoBF, followed by declines in CoBF (Flynn et al., 1988) . Similarly, intraarterial infusion of several doses of angiotensin II (AH) (10, 100 and 1000 pmol) induced large, sustained elevations of systemic blood pressure in spontaneously hypertensive rats (SHRs) accompanied by initial increases in CoBF, and subsequent slow, steady recoveries of CoBF. (Quirk et al., 1988) . In the same study, AII-induced increases in systemic blood pressure in normotensive WistarKyoto (WKY) rats were generally followed by sustained increases in CoBF. However, infusion of the high dose of AI1 (1000 pmol) resulted in similar increases in systemic blood pressure and CoBF, but during the final minute of the 5-min infusion period CoBF decreased sharply.
In the present study, we extended the intraarterial infusion period from 5-10 min to provide ample time for CoBF autoregulation to occur in the WKY rat. Phenylephrine was also infused for 10 min to test the effect of another vasoactive compound on autoregulation.
To determine the possible contribution of vascular AI1 receptors to CoBF autoregulation by vasoconstriction of the cochlea's supplying vessels, AI1 was infused into the artery supplying the cochlear artery and changes in blood pressure and CoBF were measured. Another group of animals were pretreated with a specific, AII-receptor antagonist to test for possible disruption of the AII-induced vasoconstriction. (100 and 2 mg/ml respectively; 1 ml/kg i.m.). Body temperature was monitored with a rectal probe and maintained at 38 f 1°C with heating pads. A flow-through catheter designed to allow infusion and continuous recording of blood pressure ( Fig. 1) was inserted into the right carotid artery. The catheter was constructed of PE-60 (Clay Adams) tubing, a hand-blown glass double t-junction and two 3 ml syringes. Appro~mately 2 cm of the carotid artery was exposed and both distal and proximal points of the exposure were retracted. Two 8 cm lengths of PE-60 tubing were connected to the double t-junction, filled with heparinized saline (75 U/ml 0.15 M NaCl), crossed and inserted into separate cuts made in the retracted portions of the artery and sutured in place. An additional suture was tied at the crossing point of the PE-40 tubing to prevent distortion of the artery and to further secure the catheter. Blood was allowed to flow through the catheter loop replacing the 0.3 ml of heparinized saline. Preliminary testing showed that the addition of this amount of saline to the systemic circulation did not alter blood pressure or CoBF baselines. Additionally, treatment of the glass t-junctions with sigma coate (SL-2, Sigma Chemical Co.) and the polyethelene tubing with tomac heparin complex (2%: Polysciences, Inc.) reduced and in most cases eliminated any build up of platelets in the catheter system. The end of the t-junction marked 'A' in The animal's head was secured in a head holder and the right bulla was exposed and opened for access to the cochlea according to the procedure described by Miller et al. (1983) . The laser Doppler probe (Optokinetics Corp., Advanced Model 2100) was placed on the basal turn of the cochlea. Baseline measures were obtained for both blood pressure and CoBF.
Method

Protocol
One group of 8 WKY animals was infused for 10 min with 1000 pmol/kg/min of AI1 (U.S. Biochemical) in sterile 0.15 M NaCl at a rate of 50 ~l/min. A second group of 8 animals was treated equivalently, however, phenylephrine (0.02 mg/kg/min in sterile 0.15 M NaCl at 50 pl/min) was substituted for AII. A final group of 8 control animals was infused with 0.15 M NaCl at a rate of 50 ~l/rnin. Blood pressure and CoBF were monitored throughout the infusion period and for a 15-min recovery period.
Statistical analysis
Baseline blood pressures were analyzed using a one-way analysis of variance (ANOVA): Absolute mm Hg changes in blood pressure from baseline were converted to percentages to allow differences between blood pressure and CoBF to be analyzed with a one-way repeated measures ANOVA.
Experiment 2: Anterior inferior cerebellar artery (AICA) infusion of AI1
Preparations
Each animal was anesthetized as previously described and the right carotid artery was catheterized using PE-50 tubing as described by Wright et al. (1985b) for blood pressure measurement. The right bulla was exposed and opened for access to the cochlea according to the procedure described by Miller et al. (1983) and the tissues posterior and medial to the bulla were dissected to allow access to the AICA. The laser Doppler flowmeter probe was placed on the basal turn of the cochlea. Baseline measures were obtained for both blood pressure and CoBF.
Infusion into the AICA was accomp~shed with an insulin pump (Travenol Laboratories, Model AS6MP) calibrated to deliver 100 nl/min through a 1 ml syringe. One end of a 20 cm length of PE-10 tubing was secured to the syringe via a 30 ga syringe needle and the other end was inserted into the blunt end of a glass micropipette. The tip of the pipette was pulled to an external diameter of appro~mately 15 pm. The infusion catheter line was loaded with peptide and 0.5% Evans blue dye in distilled water, separated by 100 nl of air. The micropipette tip penetrated to a depth of approximately 2 pm and was inserted such that it ran parallel with the vessel, thereby minimizing obstruction of blood flow.
Protozoa
One group of 11 animals was infused with 0.15 M NaCl for 10 min. Two additional groups of 11 animals were infused with AI1 (10 or 100 pmol/lOO nl in 0.15 M NaCl) at a rate of 100 nl/min for 10 min. A final group of animals was infused with a pretreatment of sarthran (50 nmol/lOO nl in 0.15 M NaCl) or vehicle (0.15 M NaCl) at a rate of 100 nl/min for 10 min, followed 5 min later with AI1 (100 pmol/lOO nl 0.15 M NaCl) at a rate of 100 nl/min for 10 min. Blood pressure and CoBF were monitored throughout the infusion period and for a 15-min recovery period.
Baseline blood pressures were analyzed using a one-way analysis of variance. Absolute changes in blood pressure and percentage changes in CoBF from baseline were analyzed using a repeated measures one-way analysis of variance (ANOVA).
Results
Experiment 1: Intra-arterial infusion of AII and phenylephrine
There was no significant difference in the baseline blood pressure between groups as established during the 10 min period prior to infusion. The mean baseline blood pressure and SEM for each group was 83.1 + 2.8 mm Hg, 86.7 + 2.3 mm Hg and 85.9 + 3.7 mm Hg (AII, phenylephrine and 0.15 M NaCl, respectively). Infusion of 0.15 M NaCl did not induce any changes in blood pressure or CoBF as has previously been demonstrated (Quirk et al., 1988) . Infusion of 1000 pmol of AI1 resulted in a mean + SEM blood pressure increase of 59.5 f 4.6 mm Hg, followed by a plateau at approximately 60 mm Hg above baseline (Fig. 2, A) . CoBF showed an initial increase for the first 4 min of AI1 infusion reaching a mean f SEM of 50.2 + 2.3% above baseline followed by a slow, steady decline toward baseline throughout the remainder of the infusion period (Fig. 2, B) . When blood pressure data were converted from absolute mm Hg to percent changes, there was a significant difference between AII-induced changes in systemic blood pressure and CoBF over time (F = 10.22, df = 1,14, P -c 0.01). In summary, blood pressure remained elevated throughout the infusion period while CoBF showed an initial increase followed by a slow decrease toward baseline measures. Infusion of phenylephrine was characterized by a slow consistent increase in blood pressure throughout the infusion period to a maximum increase of 53 k 6.3 mm Hg above baseline at the 10 min time point (Fig. 2, A) . However, CoBF showed an initial 27 I~I 4.1% increase by minute 3 of the phenylephrine infusion followed by a decrease and plateau at approximately 21 -t_ 3.7% for the next 4 min of the lo-min infusion period. The final 3 min of the infusion was characterized by a steady decline to 13 + 5.7% above baseline by the end of the infusion period (Fig. 2, B) . When blood pressure data were converted from absolute change in mm Hg to percent changes, there was a significant difference between blood pressure and CoBF changes over time with the lo-min phenylephrine infusion (F = 16.53, df = 1,14, P < 0.001). In summary,
CoBF slowly returned to baseline following an initial increase while blood pressure increased and remained elevated throughout the infusion period.
Experiment 2: AICA infusion of All
There was no significant difference in the baseline blood pressure between groups as established during the 70 min prior to infusion.
The mean baseline blood pressure for all groups was 84.2 + 3.5 mm Hg. There was no change in systemic blood pressure in response to AICA infusions of 0.15 M NaCl or AH (10 or lOO/pmol/min; Fig. 3 . A). However, there was a significant change in CoBF among groups during the infusions of 0.15 M NaCl, 10 and 100 pmol/min of AI1 (F = 29.67. df = 2,30, P -c 0.001). Infusion of 0.15 M NaCl did not change CoBF (Fig. 3, B) , however, infusion of 10 pmol/min AI1 resulted in a steady decrease (mean = -6.8 + 0.9%) in CoBF during the lo-min infusion period that was significantly different from 0.15 M NaCl infusion (F = 21.28, df = 1,20, P < 0.001; Fig. 3, B ) . Infusion of 100 pmol/min AI1 (Fig. 3, B ) also decreased CoBF (mean = -14.8 + 1.2%) during the infusion period and was significantly different than both 0.15 M NaCl-(F = 47.31, df = 1,20, P < 0.001) and 10 pmol/min AII-induced changes in CoBF (F = 14.59, df = 1,20, P < 0.001).
There was no change in systemic blood pressure in response to 100 pmol/min AI1 infusion in animals pretreated with sarthran or 0.15 M NaCl (Fig. 4, A) . Animals pretreated with 0.15 M NaCl and infused with AI1 (100 pmol/min) resulted in a persistent decrease in CoBF (mean = -7.6 5 1.0%) during the lo-min period. However, sarthran pretreatment diminished AII-induced decreases in CoBF (Fig. 4, B) . A significantly (F = 14.17, df = 1,6, P -c 0.01) greater decrease ia CoBF was observed in animals pretreated with 0.15 M NaCl (mean = -7.6 + 1.0%) than in animals pretreated with sarthran (mean = -0.6 f 0.5%) in response to AI1 infusion.
Discussion
The interpretation that CoBF is subject to autoregulation has received support in recent studies (Dengerink et al., 1985; Flynn et al., 1988; Hultcrantz et al., 1982; LaRouere et al., 1988; Miller et al., 1983 Miller et al., , 1984 Quirk et al., 1988) . Since cochlear blood flow has been proposed to be similar to cerebral blood flow (Lawrence et al., 1977; Miller et al., 1983) then the well-documented autoregulation of cerebral vessels (e.g. Baumbach and Heistad, 1985) supports the probability that CoBF may be autoregulated as well. The current study addressed the issue of whether CoBF in WKY rats is subject to autoregulation during sustained elevations in blood pressure. A previous investigation demonstrated a pattern of CoBF changes that could be interpreted as a form of autoregulation in the later stages of a 5-min controlled infusion of AI1 (1000 pmol/kg/ min) in WKY rats (Quirk et al., 1988) . To test this possibility the infusion period was extended to 10 rnin in the present study. Additionally, we were interested in determining whether autoregulation of CoBF could be induced by another vasoactive compound, phenylephrine. AI1 has an influence on vascular resistance through direct action on vascular smooth muscle as well as an indirect effect on the central nervous system, resulting in activation of the sympathetic nervous system, and stimulation of vasopressin and catecholamine release (for review see Phillips, 1987) . Phenylephrine, on the other hand, is a sympathomimetic drug that elevates blood pressure by increasing heart rate, the heart's conduction and contractility, as well as stimulation of epinephrine and norepinephrine release from the adrenal medulla (for review see Seiden and Dykstra, 1977) . These vasoconstrictive compounds are often used for comparison of substances that elevate blood pressure through different modes of action. The results demonstrated that elevations of systemic blood pressure induced by IO-mm infusions of both AI1 and phenylephrine resulted in an initial increase in CoBF followed by a slow, steady decline toward baseline. Since this response occurred during 5-min infusions of the same dose of AI1 in SHRs in a previous study (Quirk et al., 1988) , the present results are consistent with our interpretation that both WKY rats and SHRs exhibit an autoregulatory response, however, there appears to be a more rapid onset and greater intensity of the response in SHRs.
It is not clear whether there is any physiological significance associated with this strain difference in CoBF. However, it is interesting to note that alterations in CoBF in SHRs are correlated with times of increased metabolic need, such as the increases in blood pressure that may accompany noise exposure (Wright et al., 1981; Dengerink et al., 1982) .
A second major question of the current study addressed the possiblity that the interaction of AI1 and vascular angiotensin receptors may participate in the regulation of CoBF. During controlled elevations of blood pressure induced by systemic infusions of vasoactive compounds, the typical CoBF pattern is an initial increase followed by a slow and steady return toward baseline measures. One possible explanation for this pattern is that during large elevations in blood pressure there are increased levels of circulating vasoactive substances. Binding of these compounds to vascular receptors in the supplying vessels of the cochlea may induce vasoconstriction and subsequent decreases in CoBF.
Previous investigations measured significant increases in circulating levels of AI1 during and following noise exposure in alert rats (Wright et al., 1981 This supression effect is presumably through competitive occupation of vascular AI1 receptors. These findings support the participatory role of AI1 vascular receptors in CoBF autoregulation, are consistent with the finding that AI1 receptors are present in a number of vascular beds (Shiffrin et al., 1984) and increase the possibility that AI1 receptors may be found in the vessels supplying the cochlea.
There are a number of limitations concerning the interpretation of the present results. First, preliminary studies demonstrated that local infusions of AI1 produced elevations in systemic blood pressure if pipette tips with external diameters larger than 20 pm, or infusion rates greater than or equal to 1 ~l/min, were utilized. Second, it is clear from the present results that exogenously applied AI1 can induce vascular vasoconstriction. However, it is probable that other circulating vasoactive hormones and peptides are also involved in CoBF regulation. Finally, the laser Doppler flowmeter provides only a relative measure of CoBF. Laser Doppler measures have, however, been validated against histological measures (Dengerink and Axelsson, 1988) intravital microscopy (LaRouere et al., 1988) and radiotracer clearance (Jung, 1988) .
The micropipette infusion system utilized in the current study to infuse into the supplying vessels of the cochlea appears to be a valuable technique for assessing local regulation of CoBF. Currently, studies have been initiated using this technique to infuse other vasoactive hormones and peptides, as well as therapeutic agents. Additionally, measures of red blood cell velocity and vessel diameter changes are now being assessed using intravital microscopy (Nuttall, 1987) .
In summary, the results of the current experiment support the interpretation that CoBF in WKY rats is subject to autoregulation in response to elevations in systemic blood pressure induced by infusion of both AI1 and phenylepherine.
Additionally, decreases in CoBF may be induced by cochlear infusion of AI1 independent of changes in systemic blood pressure. This AII-induced decrease in CoBF can be inhibited by pretreatment with the competitive angiotensin receptor antagonist, sarthran. These results support the hypothesis that AI1 binding to vascular receptors induces vasoconstriction of the vessels supplying the cochlea, and therefore may be involved in CoBF autoregulation.
